Wealth-based inequalities in the uptake of three or more doses of intermittent preventive treatment in pregnancy in West Africa, 2015-2021.

ABSTRACT:

Background

Anaemia in pregnancy remains a major public health challenge in sub-Saharan Africa, contributing to adverse birth outcomes, including low birth weight and neonatal mortality. The World Health Organization (WHO) recommends the uptake of intermittent preventive treatment during pregnancy with at least three doses of sulfadoxine-pyrimethamine (IPTp-SP3) to reduce these adverse outcomes. Achieving equitable distribution of IPTp-SP3 is essential for advancing Sustainable Development Goal 3 (SDG3), which aims to achieve universal health coverage and equitable access to healthcare services for all men and women. However, continued disparities in the uptake of IPTp3 across socioeconomic groups are evident in many African countries. This study, therefore, investigates wealth-base

SUBMITTER: Inusah AW 

PROVIDER: S-EPMC12687513 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature